Covid 19 Pandemic From Ethical ViewNCT04344938
Covid 19 Pandemic. Emerging Legal and Ehical Disputes Over Patient Confidentiality
An observational study of Covid 19 Pandemic From Ethical View, run by Assiut University.
Trial summary
Many critical ethical questions arise in pandemic covid 19planning, preparedness and response. These include: Who will get priority access to medications, vaccines and intensive care unit beds, given the potential shortage of these essential resources? In the face of a pandemic, what obligations do health-care workers… Read more about this study
- Who is it for?
- Ages 18 to 60 years
- Conditions the study is for
- Covid 19 Pandemic From Ethical View
- What is being tested?
- questionnair about Emerging Legal and Ehical Disputes Over Patient Confidentiality
- Type of treatment
- Vaccines
- How many people
- 874 participants
- Where
- No sites listed yet
- Study dates
- Apr 2020to Jul 2020
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 to 60 years
- All sexes
- No healthy volunteers
- Adult
Study population: medical and non medical personel
Who may be able to join
- adult aged 18 years to 60 years
- medical personel graduated from egyptian faculty of medicine.
- non medical personel live in egypt
Who cannot join
- personel less than 18 years old .
- medical personel not graduated from egyptian faculty of medicine.
- non medical personel live outside egypt
About this study
Many critical ethical questions arise in pandemic covid 19planning, preparedness and response. These include: Who will get priority access to medications, vaccines and intensive care unit beds, given the potential shortage of these essential resources? In the face of a pandemic, what obligations do health-care workers have to work not withstanding risks to their own health and the health of their families? How can surveillance, isolation, quarantine and social-distancing measures be undertaken in a way that respects ethical norms? What obligations do countries have to one another with respect to pandemic covid 19 planning and response efforts?
- Conditions
- Covid 19 Pandemic From Ethical View
- Being tested
- questionnair about Emerging Legal and Ehical Disputes Over Patient Confidentiality
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
questionnair about Emerging Legal and Ehical Disputes Over Patient ConfidentialityOther
Many critical ethical questions arise in pandemic covid 19planning, preparedness and response. These include: Who will get priority access to medications, vaccines and intensive care unit beds, given the potential shortage of these essential resources? In the face of a pandemic, what obligations do health-care workers have to work notwithstanding risks to their own health and the health of their families? How can surveillance, isolation, quarantine and social-distancing measures be undertaken in a way that respects ethical norms? What obligations do countries have to one another with respect to pandemic covid 19 planning and response efforts?
| Study group | Role | What they receive |
|---|---|---|
| medical personel | Not described Receives: Other: questionnair about Emerging Legal and Ehical Disputes Over Patient Confidentiality | |
| non medical personel | Not described Receives: Other: questionnair about Emerging Legal and Ehical Disputes Over Patient Confidentiality |
What is being measured
The primary outcome is the main question the study is designed to answer.
Evaluate the ethical requirement of controlled disrupts of patients In case of infectious disease pandemic
questionaire done to To keep the general preventive measure in the community
Measured: 2 months
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted14 Apr 2020
- Study startApr 2020 (estimated)
- Primary completionJun 2020 (estimated)
- Study completionJul 2020 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Covid 19 Pandemic From Ethical ViewStudies of the same condition, open and under way.
- More trials run by Assiut UniversityThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Ecologic or community
- Time perspective
- Cross-sectional
- Enrolment
- 874 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Assiut University
- Sponsor type
- University, hospital or other
- Collaborators
- Doaa M.EL Shehaby
- Responsible party
- Principal investigator, Noha Esmael Ebrahem, Assiut University
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT04344938
- Sponsor's protocol ID
- 2020A10
- Status last verified
- Apr 2020
- First submitted
- 10 Apr 2020
- Last updated
- 17 Apr 2020
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
Study at a glance
From the registry record, last updated by the sponsor on 17 Apr 2020. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Covid 19 Pandemic. Emerging Legal and Ehical Disputes Over Patient Confidentiality
- ClinicalTrials.gov ID
- NCT04344938
- Acronym / sponsor ID
- 2020A10
- Conditions
- Covid 19 Pandemic From Ethical View
- Study type
- Observational
- Recruitment status
- Unknown status
- Enrolment
- 874 participants (estimated)
- Lead sponsor
- Assiut UniversityUniversity, hospital or other
- Collaborators
- Doaa M.EL Shehaby
- Study start
- Apr 2020 (estimated)
- Primary completion
- Jun 2020 (estimated)
- Study completion
- Jul 2020 (estimated)
- First posted
- 14 Apr 2020 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Many critical ethical questions arise in pandemic covid 19planning, preparedness and response. These include: Who will get priority access to medications, vaccines and intensive care unit beds, given the potential shortage of these essential resources? In the face of a pandemic, what obligations do health-care workers have to work not withstanding risks to their own health and the health of their families? How can surveillance, isolation, quarantine and social-distancing measures be undertaken in a way that respects ethical norms? What obligations do countries have to one another with respect to pandemic covid 19 planning and response efforts?
Study design
- Observational model
- Ecologic or community
- Time perspective
- Cross-sectional
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| medical personel | – | Other: questionnair about Emerging Legal and Ehical Disputes Over Patient Confidentiality |
| non medical personel | – | Other: questionnair about Emerging Legal and Ehical Disputes Over Patient Confidentiality |
Who may qualify
- Ages
- 18 to 60 years
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult
- Study population
- medical and non medical personel
Key inclusion criteria (3 listed)
- adult aged 18 years to 60 years
- medical personel graduated from egyptian faculty of medicine.
- non medical personel live in egypt
Key exclusion criteria (3 listed)
- personel less than 18 years old .
- medical personel not graduated from egyptian faculty of medicine.
- non medical personel live outside egypt
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| questionnair about Emerging Legal and Ehical Disputes Over Patient ConfidentialityMany critical ethical questions arise in pandemic covid 19planning, preparedness and response. These include: Who will get priority access to medications, vaccines and intensive care unit beds, given the potential shortage of these essential resources? In the face of a pandemic, what obligations do health-care workers have to work notwithstanding risks to their own health and the health of their families? How can surveillance, isolation, quarantine and social-distancing measures be undertaken in a way that respects ethical norms? What obligations do countries have to one another with respect to pandemic covid 19 planning and response efforts? | Other | medical personel, non medical personel |
Primary outcome
Evaluate the ethical requirement of controlled disrupts of patients In case of infectious disease pandemic
Time frame: 2 months
questionaire done to To keep the general preventive measure in the community
Results and safety
Results are not available in the source record.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 17 Apr 2020.
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
The record lists no contact. Use the official record to reach the sponsor.
Questions about this trial
What is this clinical trial studying?
An observational study of Covid 19 Pandemic From Ethical View, run by Assiut University.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 3 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: status not confirmed, as of the sponsor's last update on 17 Apr 2020. Status can change between updates, so confirm with the study contact before making plans.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
Results are not available in the source record.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Evaluate the ethical requirement of controlled disrupts of patients In case of infectious disease pandemic (time frame: 2 months). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 17 Apr 2020.